CYP26A1 and breast carcinoma: As shown in Table 3 and Figure 1A and D, four of 12 target genes (RARβ2, CYP26A1, CRBP1, and RGS16) were upregulated by more than two-fold in both the RA-sensitive lung and breast cancer cells.